Mitochondrial function decreases in pasture-fed dairy cows during early lactation. by Mercedes García-Roche (6459200)

5-ALA staining of gastrointestinal cancer cells. by Noriko Kawai (6694010)

Variable importance metric as measured by mean decrease in gini index (standardized between 0 and 100) for internalizing problem behavior, based on random forest with the number of variables sampled at each split (mtry) = 5, and number of trees (ntree) = 100 fitted on the entire dataset. by Samrachana Adhikari (7818143)

Brain and liver GCase activity are significantly decreased in heterozygous <i>GBA1</i> D409V KI mice, with varying differences in glucosphingolipid lipids in brain and liver. by Nicole K. Polinski (10947787)

“…(A-B) GCase levels as assessed by the CBE/4-MU method are significantly decreased in the het <i>GBA1</i> D409V KI mice at 5 months of age in both brain (A) and liver (B). …”

Propagation of an action potential through ephaptic coupling is achieved for a decreased extracellular conductivity. by Karoline Horgmo Jæger (6785450)

Mitochondrial enzyme ALAS1 interacts with MeV-V protein. by Pierre Khalfi (7868252)

Mean positional maternal haemodynamics by individual. by Laura Ormesher (17131361)

Subjects:

Excessive free fatty acids sensing in pituitary lactotrophs elicits liver steatosis by decreasing prolactin levels by Xinlu Ji (12433917)

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

MET knockdown decreases MET expression and activation. by Karolin Ebert (7434713)

Comparison of mean differences in temperature decreases. by Hans-Jörg Gillmann (8460585)

Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Pharmacological Mechanism of the Non-hallucinogenic 5‑HT_2A Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

“…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G_q, G₁₁, and β-arrestin2) coupled to 5-HT_2A receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”

Pharmacological Mechanism of the Non-hallucinogenic 5‑HT_2A Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

“…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G_q, G₁₁, and β-arrestin2) coupled to 5-HT_2A receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”

Decreasing mean transistor size since 2000. by David Burg (8209752)

Data for Fig 5D. by Xiaohua Zhang (350570)

Phenotypes from non-MetS <i>versus</i> MetS participants in the Arizona Insulin Resistance (AIR) registry. by Keane Urashima (11625020)

Subjects:

Background characteristics of young adults and non-young adults. by Yuichiro Ohya (13040293)

Subjects:

Stroke subtype of young adults and non-young adults. by Yuichiro Ohya (13040293)

Subjects:

HVR1-swap compensatory E1/E2 substitutions typically decrease virus entry dependency on SR-BI. by Christina Holmboe Olesen (11154333)